Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Neurology|July 26, 2023
Improving door-to-reperfusion time in acute ischemic stroke during the COVID-19 pandemic: experience from a public comprehensive stroke center in BrazilMarcelo Klu, Ana Claudia de Souza, Leonardo Augusto Carbonera, et al.
Healthcare (Basel, Switzerland)|March 28, 2026
Improvements in Timely Care and Patient-Reported Outcomes for Breast Cancer: A Seven-Year Southern Brazilian Cohort AnalysisRafaela Munari da Silva, Mauricio Santiago Soper, Larissa Conrado Martins, et al.
Arquivos De Neuro-Psiquiatria|December 29, 2023
Reperfusion therapy for acute ischemic stroke: where are we in 2023?Sheila Cristina Ouriques Martins, Octávio Marques Pontes-Neto, Arthur Pille, et al.
Journal of Medical Virology|July 11, 2024
Temporal trends in respiratory pathogens following the COVID-19 pandemic and climate variables: A unicentric retrospective evaluation of 24 pathogens in a temperate subtropical regionSérgio Renato da Rosa Decker, Jonas Michel Wolf, Arthur Pille, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 5, 2023
World Stroke Organization Brain & hEart globAl iniTiative ProgramLuciano A Sposato, Sheila Martins, Jan F Scheitz, et al.
Frontiers in Neurology|May 23, 2022
Disparities in Stroke Patient-Reported Outcomes Measurement Between Healthcare Systems in BrazilSheila Cristina Ouriques Martins, Wyllians Vendramini Borelli, Thais Leite Secchi, et al.
Neuroepidemiology|August 28, 2025
Polypill and RiskOMeter to Prevent StrOke and CogniTive ImpairmEnt in Primary Health Care (PROMOTE) Randomized Clinical Trial: Rationale and DesignMichael Brainin, Craig S Anderson, Philip M Bath, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Pageof 2